| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |